TRDA Entrada Therapeutics
- 12.360
- -0.070-0.56%
- 12.360
- 0.0000.00%
Entrada Therapeutics News
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WENTWORTH KORY JAMES
Analysis
Price Target
No Data
